Amarin Corp Plc (AMRN)

[couldbebetter]

Denisk, I agree with you that Germany is absolutely key. The question that I have is
this: If some BP such as Novartis or Bayer were to acquire AMRN before any reimbursement
deal were struck, would they not have a much better chance of getting a deal done?
I believe so. Certainly certain Europe based BP must have some excellent connections
and influence with these government agencies. So why would Denner waste time on
doing something that BP could likely do with an even better deal? Then there is the
Cancer situation. I wonder if Denner understands that Vascepa could make an effective
adjunct drug for many Cancer drugs and therapies. What I am suggesting is a BP such
as Novartis that has many important Cancer therapies, be enticed into doing some
proof of concept studies to find out if Vascepa could be beneficial to Cancer patients.
I hope Denner is aware of the potential that a BP could help to unlock. In my
opinion, the sooner Denner gets a deal done the better for all concerned!